nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—DRD4—bipolar disorder	0.117	0.152	CbGaD
Amoxapine—DRD3—bipolar disorder	0.101	0.131	CbGaD
Amoxapine—DRD1—bipolar disorder	0.0994	0.128	CbGaD
Amoxapine—SLC6A3—bipolar disorder	0.0942	0.122	CbGaD
Amoxapine—HTR2C—bipolar disorder	0.085	0.11	CbGaD
Amoxapine—HTR1A—bipolar disorder	0.0825	0.107	CbGaD
Amoxapine—SLC6A4—bipolar disorder	0.0705	0.091	CbGaD
Amoxapine—DRD2—bipolar disorder	0.0701	0.0905	CbGaD
Amoxapine—HTR2A—bipolar disorder	0.0541	0.0699	CbGaD
Amoxapine—DRD3—telencephalic ventricle—bipolar disorder	0.00496	0.0674	CbGeAlD
Amoxapine—SLC6A2—locus ceruleus—bipolar disorder	0.00486	0.066	CbGeAlD
Amoxapine—HTR7—locus ceruleus—bipolar disorder	0.00468	0.0636	CbGeAlD
Amoxapine—DRD1—telencephalic ventricle—bipolar disorder	0.00355	0.0483	CbGeAlD
Amoxapine—ORM1—saliva—bipolar disorder	0.00336	0.0457	CbGeAlD
Amoxapine—HTR2A—locus ceruleus—bipolar disorder	0.00292	0.0397	CbGeAlD
Amoxapine—HTR1B—telencephalic ventricle—bipolar disorder	0.00288	0.0391	CbGeAlD
Amoxapine—SLC6A3—telencephalic ventricle—bipolar disorder	0.00286	0.0388	CbGeAlD
Amoxapine—HTR2C—telencephalic ventricle—bipolar disorder	0.00276	0.0375	CbGeAlD
Amoxapine—SLC6A2—autonomic nervous system—bipolar disorder	0.00258	0.0351	CbGeAlD
Amoxapine—HTR7—autonomic nervous system—bipolar disorder	0.00249	0.0338	CbGeAlD
Amoxapine—HTR1A—telencephalic ventricle—bipolar disorder	0.00232	0.0316	CbGeAlD
Amoxapine—HTR7—telencephalic ventricle—bipolar disorder	0.00222	0.0302	CbGeAlD
Amoxapine—DRD2—telencephalic ventricle—bipolar disorder	0.0021	0.0285	CbGeAlD
Amoxapine—HTR2A—autonomic nervous system—bipolar disorder	0.00155	0.0211	CbGeAlD
Amoxapine—HTR2A—telencephalic ventricle—bipolar disorder	0.00138	0.0188	CbGeAlD
Amoxapine—HTR2A—urine—bipolar disorder	0.00126	0.0172	CbGeAlD
Amoxapine—SLC6A4—blood plasma—bipolar disorder	0.00125	0.0169	CbGeAlD
Amoxapine—CYP2D6—urine—bipolar disorder	0.00115	0.0156	CbGeAlD
Amoxapine—HTR1A—blood plasma—bipolar disorder	0.00111	0.015	CbGeAlD
Amoxapine—HTR7—blood plasma—bipolar disorder	0.00106	0.0144	CbGeAlD
Amoxapine—ADRA2A—blood plasma—bipolar disorder	0.000776	0.0105	CbGeAlD
Amoxapine—DRD4—brain—bipolar disorder	0.000765	0.0104	CbGeAlD
Amoxapine—DRD3—nervous system—bipolar disorder	0.000704	0.00955	CbGeAlD
Amoxapine—HTR6—nervous system—bipolar disorder	0.000677	0.0092	CbGeAlD
Amoxapine—HTR2A—blood plasma—bipolar disorder	0.00066	0.00896	CbGeAlD
Amoxapine—HTR2B—adrenal cortex—bipolar disorder	0.000627	0.00852	CbGeAlD
Amoxapine—CYP2D6—blood plasma—bipolar disorder	0.000601	0.00817	CbGeAlD
Amoxapine—DRD3—brain—bipolar disorder	0.000538	0.0073	CbGeAlD
Amoxapine—HTR6—brain—bipolar disorder	0.000518	0.00703	CbGeAlD
Amoxapine—DRD1—nervous system—bipolar disorder	0.000504	0.00684	CbGeAlD
Amoxapine—HTR3A—nervous system—bipolar disorder	0.000487	0.00661	CbGeAlD
Amoxapine—HTR2B—thyroid gland—bipolar disorder	0.000437	0.00593	CbGeAlD
Amoxapine—ORM1—nervous system—bipolar disorder	0.000435	0.00591	CbGeAlD
Amoxapine—HTR1B—nervous system—bipolar disorder	0.000408	0.00554	CbGeAlD
Amoxapine—GABRA1—nervous system—bipolar disorder	0.000408	0.00554	CbGeAlD
Amoxapine—SLC6A3—nervous system—bipolar disorder	0.000405	0.0055	CbGeAlD
Amoxapine—HTR2C—nervous system—bipolar disorder	0.000391	0.00531	CbGeAlD
Amoxapine—DRD1—brain—bipolar disorder	0.000385	0.00523	CbGeAlD
Amoxapine—GABRA1—cerebellum—bipolar disorder	0.000384	0.00522	CbGeAlD
Amoxapine—SLC6A3—cerebellum—bipolar disorder	0.000381	0.00517	CbGeAlD
Amoxapine—HTR3A—brain—bipolar disorder	0.000372	0.00505	CbGeAlD
Amoxapine—SLC6A4—nervous system—bipolar disorder	0.000371	0.00504	CbGeAlD
Amoxapine—CHRM1—nervous system—bipolar disorder	0.00037	0.00502	CbGeAlD
Amoxapine—HTR2B—nervous system—bipolar disorder	0.000368	0.00499	CbGeAlD
Amoxapine—Zuclopenthixol—DRD5—bipolar disorder	0.000363	0.0564	CrCbGaD
Amoxapine—Olanzapine—DRD5—bipolar disorder	0.000346	0.0537	CrCbGaD
Amoxapine—HTR1A—nervous system—bipolar disorder	0.000329	0.00447	CbGeAlD
Amoxapine—SLC6A2—nervous system—bipolar disorder	0.000327	0.00443	CbGeAlD
Amoxapine—Asenapine—DRD4—bipolar disorder	0.000318	0.0494	CrCbGaD
Amoxapine—HTR7—nervous system—bipolar disorder	0.000315	0.00427	CbGeAlD
Amoxapine—GABRA1—brain—bipolar disorder	0.000312	0.00424	CbGeAlD
Amoxapine—HTR1B—brain—bipolar disorder	0.000312	0.00424	CbGeAlD
Amoxapine—HTR1A—cerebellum—bipolar disorder	0.00031	0.00421	CbGeAlD
Amoxapine—SLC6A3—brain—bipolar disorder	0.000309	0.0042	CbGeAlD
Amoxapine—ADRA1A—nervous system—bipolar disorder	0.000304	0.00412	CbGeAlD
Amoxapine—HTR2C—brain—bipolar disorder	0.000299	0.00406	CbGeAlD
Amoxapine—DRD2—nervous system—bipolar disorder	0.000298	0.00404	CbGeAlD
Amoxapine—HTR7—cerebellum—bipolar disorder	0.000296	0.00402	CbGeAlD
Amoxapine—ADRA1A—cerebellum—bipolar disorder	0.000286	0.00388	CbGeAlD
Amoxapine—SLC6A4—brain—bipolar disorder	0.000284	0.00385	CbGeAlD
Amoxapine—CHRM1—brain—bipolar disorder	0.000283	0.00384	CbGeAlD
Amoxapine—HTR2B—brain—bipolar disorder	0.000281	0.00382	CbGeAlD
Amoxapine—DRD2—cerebellum—bipolar disorder	0.00028	0.0038	CbGeAlD
Amoxapine—ADRA2A—thyroid gland—bipolar disorder	0.000275	0.00373	CbGeAlD
Amoxapine—Asenapine—DRD3—bipolar disorder	0.000274	0.0426	CrCbGaD
Amoxapine—Asenapine—DRD1—bipolar disorder	0.000269	0.0418	CrCbGaD
Amoxapine—HTR1A—brain—bipolar disorder	0.000252	0.00342	CbGeAlD
Amoxapine—SLC6A2—brain—bipolar disorder	0.00025	0.00339	CbGeAlD
Amoxapine—Mazindol—SLC6A3—bipolar disorder	0.000245	0.038	CrCbGaD
Amoxapine—HTR7—brain—bipolar disorder	0.000241	0.00327	CbGeAlD
Amoxapine—HRH1—nervous system—bipolar disorder	0.000235	0.00319	CbGeAlD
Amoxapine—ADRA1A—brain—bipolar disorder	0.000232	0.00315	CbGeAlD
Amoxapine—ADRA2A—nervous system—bipolar disorder	0.000231	0.00313	CbGeAlD
Amoxapine—Asenapine—HTR2C—bipolar disorder	0.00023	0.0358	CrCbGaD
Amoxapine—DRD2—brain—bipolar disorder	0.000228	0.00309	CbGeAlD
Amoxapine—Asenapine—HTR1A—bipolar disorder	0.000224	0.0347	CrCbGaD
Amoxapine—ADRA2A—cerebellum—bipolar disorder	0.000217	0.00295	CbGeAlD
Amoxapine—Loxapine—DRD5—bipolar disorder	0.000215	0.0334	CrCbGaD
Amoxapine—Quetiapine—DRD5—bipolar disorder	0.00021	0.0326	CrCbGaD
Amoxapine—HTR2A—nervous system—bipolar disorder	0.000196	0.00267	CbGeAlD
Amoxapine—Asenapine—SLC6A4—bipolar disorder	0.000191	0.0296	CrCbGaD
Amoxapine—Asenapine—DRD2—bipolar disorder	0.00019	0.0295	CrCbGaD
Amoxapine—HTR2A—cerebellum—bipolar disorder	0.000185	0.00251	CbGeAlD
Amoxapine—Mazindol—SLC6A4—bipolar disorder	0.000183	0.0284	CrCbGaD
Amoxapine—HRH1—brain—bipolar disorder	0.00018	0.00244	CbGeAlD
Amoxapine—CYP2D6—nervous system—bipolar disorder	0.000179	0.00243	CbGeAlD
Amoxapine—Olanzapine—DRD4—bipolar disorder	0.000177	0.0275	CrCbGaD
Amoxapine—ADRA2A—brain—bipolar disorder	0.000176	0.0024	CbGeAlD
Amoxapine—CYP2D6—cerebellum—bipolar disorder	0.000168	0.00229	CbGeAlD
Amoxapine—Zuclopenthixol—DRD1—bipolar disorder	0.000157	0.0244	CrCbGaD
Amoxapine—Olanzapine—DRD3—bipolar disorder	0.000153	0.0237	CrCbGaD
Amoxapine—HTR2A—brain—bipolar disorder	0.00015	0.00204	CbGeAlD
Amoxapine—Olanzapine—DRD1—bipolar disorder	0.00015	0.0233	CrCbGaD
Amoxapine—Asenapine—HTR2A—bipolar disorder	0.000147	0.0228	CrCbGaD
Amoxapine—CYP2D6—brain—bipolar disorder	0.000137	0.00186	CbGeAlD
Amoxapine—Olanzapine—HTR2C—bipolar disorder	0.000128	0.0199	CrCbGaD
Amoxapine—Olanzapine—HTR1A—bipolar disorder	0.000124	0.0193	CrCbGaD
Amoxapine—Zuclopenthixol—DRD2—bipolar disorder	0.000111	0.0172	CrCbGaD
Amoxapine—Loxapine—DRD4—bipolar disorder	0.00011	0.0171	CrCbGaD
Amoxapine—Quetiapine—DRD4—bipolar disorder	0.000107	0.0167	CrCbGaD
Amoxapine—Olanzapine—DRD2—bipolar disorder	0.000106	0.0164	CrCbGaD
Amoxapine—Loxapine—DRD3—bipolar disorder	9.49e-05	0.0147	CrCbGaD
Amoxapine—Loxapine—DRD1—bipolar disorder	9.31e-05	0.0145	CrCbGaD
Amoxapine—Quetiapine—DRD3—bipolar disorder	9.26e-05	0.0144	CrCbGaD
Amoxapine—Clozapine—DRD4—bipolar disorder	9.24e-05	0.0143	CrCbGaD
Amoxapine—Quetiapine—DRD1—bipolar disorder	9.09e-05	0.0141	CrCbGaD
Amoxapine—Loxapine—SLC6A3—bipolar disorder	8.83e-05	0.0137	CrCbGaD
Amoxapine—Zuclopenthixol—HTR2A—bipolar disorder	8.57e-05	0.0133	CrCbGaD
Amoxapine—Olanzapine—HTR2A—bipolar disorder	8.16e-05	0.0127	CrCbGaD
Amoxapine—Loxapine—HTR2C—bipolar disorder	7.97e-05	0.0124	CrCbGaD
Amoxapine—Clozapine—DRD3—bipolar disorder	7.96e-05	0.0124	CrCbGaD
Amoxapine—Clozapine—DRD1—bipolar disorder	7.82e-05	0.0121	CrCbGaD
Amoxapine—Quetiapine—HTR2C—bipolar disorder	7.77e-05	0.0121	CrCbGaD
Amoxapine—Loxapine—HTR1A—bipolar disorder	7.73e-05	0.012	CrCbGaD
Amoxapine—Quetiapine—HTR1A—bipolar disorder	7.55e-05	0.0117	CrCbGaD
Amoxapine—Clozapine—HTR2C—bipolar disorder	6.69e-05	0.0104	CrCbGaD
Amoxapine—Loxapine—SLC6A4—bipolar disorder	6.6e-05	0.0102	CrCbGaD
Amoxapine—Loxapine—DRD2—bipolar disorder	6.56e-05	0.0102	CrCbGaD
Amoxapine—Clozapine—HTR1A—bipolar disorder	6.49e-05	0.0101	CrCbGaD
Amoxapine—Quetiapine—DRD2—bipolar disorder	6.41e-05	0.00995	CrCbGaD
Amoxapine—Clozapine—DRD2—bipolar disorder	5.51e-05	0.00856	CrCbGaD
Amoxapine—Loxapine—HTR2A—bipolar disorder	5.07e-05	0.00788	CrCbGaD
Amoxapine—Quetiapine—HTR2A—bipolar disorder	4.95e-05	0.00769	CrCbGaD
Amoxapine—Clozapine—HTR2A—bipolar disorder	4.26e-05	0.00661	CrCbGaD
Amoxapine—DRD3—GPCR downstream signaling—POMC—bipolar disorder	7.48e-06	5.14e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—S100B—bipolar disorder	7.43e-06	5.11e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—NTRK1—bipolar disorder	7.43e-06	5.11e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—S100B—bipolar disorder	7.42e-06	5.11e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—HTR2A—bipolar disorder	7.41e-06	5.1e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—HTR2A—bipolar disorder	7.37e-06	5.07e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—HTR1A—bipolar disorder	7.35e-06	5.06e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—ADCY2—bipolar disorder	7.34e-06	5.05e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TCF7L2—bipolar disorder	7.32e-06	5.04e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—NTRK1—bipolar disorder	7.31e-06	5.03e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—POMC—bipolar disorder	7.3e-06	5.02e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TAC1—bipolar disorder	7.28e-06	5.01e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—DRD2—bipolar disorder	7.27e-06	5e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—ADCY2—bipolar disorder	7.25e-06	4.99e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TAC1—bipolar disorder	7.24e-06	4.98e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—S100B—bipolar disorder	7.22e-06	4.97e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TCF7L2—bipolar disorder	7.22e-06	4.97e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—ADM—bipolar disorder	7.2e-06	4.95e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—DRD2—bipolar disorder	7.17e-06	4.93e-05	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—HTR2A—bipolar disorder	7.16e-06	4.93e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—HTR2C—bipolar disorder	7.14e-06	4.91e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—DRD1—bipolar disorder	7.14e-06	4.91e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—S100B—bipolar disorder	7.11e-06	4.89e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—DRD1—bipolar disorder	7.1e-06	4.88e-05	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—HTR2A—bipolar disorder	7.03e-06	4.84e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TSHB—bipolar disorder	7.01e-06	4.83e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PDE4B—bipolar disorder	7.01e-06	4.83e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TACR1—bipolar disorder	7.01e-06	4.83e-05	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—HTR2A—bipolar disorder	7.01e-06	4.82e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—NTRK1—bipolar disorder	6.98e-06	4.8e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—NTRK2—bipolar disorder	6.94e-06	4.78e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—DRD3—bipolar disorder	6.91e-06	4.75e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—NTRK2—bipolar disorder	6.91e-06	4.75e-05	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—HTR2A—bipolar disorder	6.9e-06	4.75e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—POMC—bipolar disorder	6.88e-06	4.74e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—GSK3A—bipolar disorder	6.88e-06	4.73e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—DRD3—bipolar disorder	6.87e-06	4.73e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—GSK3A—bipolar disorder	6.84e-06	4.71e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—POMC—bipolar disorder	6.79e-06	4.67e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—S100B—bipolar disorder	6.78e-06	4.67e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—DRD4—bipolar disorder	6.71e-06	4.62e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—SNAP25—bipolar disorder	6.71e-06	4.61e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—DRD4—bipolar disorder	6.67e-06	4.59e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—NTRK1—bipolar disorder	6.58e-06	4.53e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—NRG1—bipolar disorder	6.56e-06	4.51e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—NRG1—bipolar disorder	6.55e-06	4.51e-05	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—POMC—bipolar disorder	6.52e-06	4.48e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—HTR2A—bipolar disorder	6.51e-06	4.48e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—NTRK1—bipolar disorder	6.49e-06	4.47e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—HTR1A—bipolar disorder	6.49e-06	4.46e-05	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—POMC—bipolar disorder	6.48e-06	4.46e-05	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—HTR2A—bipolar disorder	6.41e-06	4.41e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—S100B—bipolar disorder	6.4e-06	4.4e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TAC1—bipolar disorder	6.39e-06	4.4e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—HTR2A—bipolar disorder	6.39e-06	4.4e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—HTR1A—bipolar disorder	6.38e-06	4.39e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—NRG1—bipolar disorder	6.37e-06	4.38e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—HTR1A—bipolar disorder	6.37e-06	4.38e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—HTR2A—bipolar disorder	6.37e-06	4.38e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—HTR1A—bipolar disorder	6.35e-06	4.37e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—ADCY2—bipolar disorder	6.31e-06	4.35e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—S100B—bipolar disorder	6.31e-06	4.34e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TCF7L2—bipolar disorder	6.29e-06	4.33e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TAC1—bipolar disorder	6.29e-06	4.33e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—ADCY2—bipolar disorder	6.28e-06	4.32e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TAC1—bipolar disorder	6.27e-06	4.32e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—NRG1—bipolar disorder	6.27e-06	4.32e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—HTR2A—bipolar disorder	6.27e-06	4.31e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—HTR2C—bipolar disorder	6.26e-06	4.31e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—DRD1—bipolar disorder	6.26e-06	4.31e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TCF7L2—bipolar disorder	6.26e-06	4.31e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TAC1—bipolar disorder	6.25e-06	4.3e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—HTR1A—bipolar disorder	6.25e-06	4.3e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—DRD2—bipolar disorder	6.25e-06	4.3e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—DRD2—bipolar disorder	6.22e-06	4.28e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—HTR2C—bipolar disorder	6.16e-06	4.24e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—DRD1—bipolar disorder	6.16e-06	4.24e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TAC1—bipolar disorder	6.15e-06	4.23e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—HTR2C—bipolar disorder	6.15e-06	4.23e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—DRD1—bipolar disorder	6.15e-06	4.23e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—HTR2C—bipolar disorder	6.13e-06	4.22e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—DRD1—bipolar disorder	6.13e-06	4.22e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NTRK2—bipolar disorder	6.09e-06	4.19e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—DRD3—bipolar disorder	6.07e-06	4.17e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—GSK3A—bipolar disorder	6.04e-06	4.16e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—DRD1—bipolar disorder	6.04e-06	4.15e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—HTR2C—bipolar disorder	6.04e-06	4.15e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NTRK2—bipolar disorder	6e-06	4.13e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—NRG1—bipolar disorder	5.99e-06	4.12e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NTRK2—bipolar disorder	5.98e-06	4.12e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—DRD3—bipolar disorder	5.97e-06	4.11e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NTRK2—bipolar disorder	5.96e-06	4.1e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—DRD3—bipolar disorder	5.96e-06	4.1e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—GSK3A—bipolar disorder	5.94e-06	4.09e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—DRD3—bipolar disorder	5.94e-06	4.09e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—ADCY2—bipolar disorder	5.94e-06	4.08e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—GSK3A—bipolar disorder	5.93e-06	4.08e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—POMC—bipolar disorder	5.92e-06	4.07e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—HTR2A—bipolar disorder	5.91e-06	4.07e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—GSK3A—bipolar disorder	5.91e-06	4.07e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—HTR2A—bipolar disorder	5.91e-06	4.06e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—DRD4—bipolar disorder	5.89e-06	4.05e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—POMC—bipolar disorder	5.89e-06	4.05e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NTRK2—bipolar disorder	5.87e-06	4.04e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—DRD3—bipolar disorder	5.85e-06	4.02e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—HTR2A—bipolar disorder	5.82e-06	4.01e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—GSK3A—bipolar disorder	5.82e-06	4e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—HTR1A—bipolar disorder	5.81e-06	4e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—DRD4—bipolar disorder	5.8e-06	3.99e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—DRD4—bipolar disorder	5.78e-06	3.98e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—DRD4—bipolar disorder	5.76e-06	3.97e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—HTR2A—bipolar disorder	5.75e-06	3.95e-05	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—POMC—bipolar disorder	5.72e-06	3.94e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TAC1—bipolar disorder	5.72e-06	3.93e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—DRD4—bipolar disorder	5.67e-06	3.9e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—NTRK1—bipolar disorder	5.66e-06	3.89e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—HTR2A—bipolar disorder	5.65e-06	3.89e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—NRG1—bipolar disorder	5.65e-06	3.88e-05	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—POMC—bipolar disorder	5.63e-06	3.87e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—NTRK1—bipolar disorder	5.63e-06	3.87e-05	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—POMC—bipolar disorder	5.62e-06	3.87e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CLOCK—bipolar disorder	5.61e-06	3.86e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—HTR2C—bipolar disorder	5.61e-06	3.86e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—DRD1—bipolar disorder	5.61e-06	3.86e-05	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—POMC—bipolar disorder	5.6e-06	3.85e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—NRG1—bipolar disorder	5.57e-06	3.83e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—ADCY2—bipolar disorder	5.54e-06	3.82e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TCF7L2—bipolar disorder	5.52e-06	3.8e-05	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—POMC—bipolar disorder	5.51e-06	3.79e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—S100B—bipolar disorder	5.5e-06	3.78e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—S100B—bipolar disorder	5.47e-06	3.77e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—TSHB—bipolar disorder	5.47e-06	3.76e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—TPH2—bipolar disorder	5.47e-06	3.76e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CACNB2—bipolar disorder	5.47e-06	3.76e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—ADCY2—bipolar disorder	5.46e-06	3.75e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NTRK2—bipolar disorder	5.46e-06	3.75e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—ADCY2—bipolar disorder	5.44e-06	3.75e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TCF7L2—bipolar disorder	5.44e-06	3.74e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—DRD3—bipolar disorder	5.43e-06	3.74e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—ADCY2—bipolar disorder	5.43e-06	3.73e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TCF7L2—bipolar disorder	5.42e-06	3.73e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—GSK3A—bipolar disorder	5.41e-06	3.72e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TCF7L2—bipolar disorder	5.41e-06	3.72e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—DRD2—bipolar disorder	5.4e-06	3.71e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—HTR2A—bipolar disorder	5.4e-06	3.71e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—DRD2—bipolar disorder	5.39e-06	3.71e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—DPYD—bipolar disorder	5.38e-06	3.7e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—DRD2—bipolar disorder	5.37e-06	3.7e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—ADCY2—bipolar disorder	5.34e-06	3.68e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TCF7L2—bipolar disorder	5.32e-06	3.66e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—DRD2—bipolar disorder	5.29e-06	3.64e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—DRD4—bipolar disorder	5.27e-06	3.63e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—POMC—bipolar disorder	5.2e-06	3.58e-05	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—POMC—bipolar disorder	5.12e-06	3.52e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—POMC—bipolar disorder	5.11e-06	3.52e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—POMC—bipolar disorder	5.1e-06	3.51e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—HTR2A—bipolar disorder	5.09e-06	3.5e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—POMC—bipolar disorder	5.08e-06	3.5e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—COMT—bipolar disorder	5.08e-06	3.5e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—MAOA—bipolar disorder	5.05e-06	3.47e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—HTR2A—bipolar disorder	5.02e-06	3.46e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—POMC—bipolar disorder	5.01e-06	3.44e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CACNA1C—bipolar disorder	5e-06	3.44e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NTRK1—bipolar disorder	4.97e-06	3.42e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—ADCY2—bipolar disorder	4.96e-06	3.42e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TCF7L2—bipolar disorder	4.95e-06	3.4e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—DRD2—bipolar disorder	4.91e-06	3.38e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NTRK1—bipolar disorder	4.89e-06	3.36e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NTRK1—bipolar disorder	4.88e-06	3.36e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	4.87e-06	3.35e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NTRK1—bipolar disorder	4.86e-06	3.35e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—NRG1—bipolar disorder	4.85e-06	3.34e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—NRG1—bipolar disorder	4.83e-06	3.32e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—S100B—bipolar disorder	4.83e-06	3.32e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NTRK1—bipolar disorder	4.79e-06	3.29e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—GSK3B—bipolar disorder	4.76e-06	3.28e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—GSK3B—bipolar disorder	4.76e-06	3.27e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—S100B—bipolar disorder	4.75e-06	3.27e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—S100B—bipolar disorder	4.74e-06	3.26e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—S100B—bipolar disorder	4.73e-06	3.25e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—POMC—bipolar disorder	4.72e-06	3.25e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—POMC—bipolar disorder	4.72e-06	3.25e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—INS—bipolar disorder	4.7e-06	3.23e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—INS—bipolar disorder	4.69e-06	3.23e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—S100B—bipolar disorder	4.65e-06	3.2e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—POMC—bipolar disorder	4.65e-06	3.2e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—GSK3B—bipolar disorder	4.63e-06	3.18e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—POMC—bipolar disorder	4.59e-06	3.16e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—INS—bipolar disorder	4.56e-06	3.14e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—GSK3B—bipolar disorder	4.55e-06	3.13e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—POMC—bipolar disorder	4.52e-06	3.11e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—INS—bipolar disorder	4.49e-06	3.09e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NTRK1—bipolar disorder	4.45e-06	3.06e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—HTR2A—bipolar disorder	4.38e-06	3.01e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—SNAP25—bipolar disorder	4.37e-06	3.01e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—HTR2A—bipolar disorder	4.35e-06	3e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—GSK3B—bipolar disorder	4.35e-06	2.99e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—S100B—bipolar disorder	4.32e-06	2.97e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—POMC—bipolar disorder	4.31e-06	2.97e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—INS—bipolar disorder	4.29e-06	2.95e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NRG1—bipolar disorder	4.26e-06	2.93e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NRG1—bipolar disorder	4.19e-06	2.89e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NRG1—bipolar disorder	4.18e-06	2.88e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NRG1—bipolar disorder	4.17e-06	2.87e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—MTHFR—bipolar disorder	4.11e-06	2.83e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NRG1—bipolar disorder	4.11e-06	2.83e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—GSK3B—bipolar disorder	4.1e-06	2.82e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—POMC—bipolar disorder	4.07e-06	2.8e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—GSK3B—bipolar disorder	4.04e-06	2.78e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—INS—bipolar disorder	4.04e-06	2.78e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—POMC—bipolar disorder	4.01e-06	2.76e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—INS—bipolar disorder	3.99e-06	2.74e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—ADCY2—bipolar disorder	3.87e-06	2.66e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—HTR2A—bipolar disorder	3.84e-06	2.64e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NRG1—bipolar disorder	3.82e-06	2.63e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—HTR2A—bipolar disorder	3.77e-06	2.6e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—HTR2A—bipolar disorder	3.76e-06	2.59e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—HTR2A—bipolar disorder	3.7e-06	2.55e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—GSK3B—bipolar disorder	3.52e-06	2.42e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—GSK3B—bipolar disorder	3.51e-06	2.41e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—POMC—bipolar disorder	3.5e-06	2.41e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—POMC—bipolar disorder	3.48e-06	2.39e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—INS—bipolar disorder	3.48e-06	2.39e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—INS—bipolar disorder	3.46e-06	2.38e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—HTR2A—bipolar disorder	3.44e-06	2.37e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—COMT—bipolar disorder	3.31e-06	2.28e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—MAOA—bipolar disorder	3.29e-06	2.26e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—POMC—bipolar disorder	3.29e-06	2.26e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—INS—bipolar disorder	3.27e-06	2.25e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—GSK3B—bipolar disorder	3.09e-06	2.13e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—POMC—bipolar disorder	3.07e-06	2.11e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—INS—bipolar disorder	3.05e-06	2.1e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—GSK3B—bipolar disorder	3.04e-06	2.09e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—GSK3B—bipolar disorder	3.04e-06	2.09e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—GSK3B—bipolar disorder	3.03e-06	2.08e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—POMC—bipolar disorder	3.02e-06	2.08e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—POMC—bipolar disorder	3.01e-06	2.07e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—POMC—bipolar disorder	3e-06	2.07e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—INS—bipolar disorder	3e-06	2.07e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—INS—bipolar disorder	3e-06	2.06e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—INS—bipolar disorder	2.99e-06	2.06e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—GSK3B—bipolar disorder	2.98e-06	2.05e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—POMC—bipolar disorder	2.96e-06	2.03e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—INS—bipolar disorder	2.94e-06	2.02e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—GSK3B—bipolar disorder	2.77e-06	1.91e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—POMC—bipolar disorder	2.75e-06	1.89e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—INS—bipolar disorder	2.73e-06	1.88e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—MTHFR—bipolar disorder	2.68e-06	1.84e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—POMC—bipolar disorder	2.14e-06	1.47e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—INS—bipolar disorder	2.13e-06	1.47e-05	CbGpPWpGaD
